Ischemia‐modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in <scp>A</scp>lzheimer's disease

Abstract

Increased IMA, AOPP and PAB, and decreased FRAP are likely to be results of oxidative stress, a condition in which an imbalance occurs between the production and inactivation of reactive oxygen species in AD. The IMA could be used for the better evaluation of clinical status, as well as the independent characteristic symptoms of AD, for the purposes of routine clinical laboratory analysis.